Dfilin M

Product Composition

According to the packaging, each uncoated bilayered tablet contains:

• Doxofylline (SR): 400 mg.

• Montelukast Sodium IP: Equivalent to Montelukast 10 mg.

• Excipients: q.s. (sufficient quantity).

• Colour: Quinoline Yellow WS.

Product Summary

Dfilin-M is a combination respiratory medication marketed by Healthgate. It combines a bronchodilator (Doxofylline in a sustained-release form) with a leukotriene receptor antagonist (Montelukast Sodium). This dual-action tablet is used for the prevention and maintenance treatment of chronic asthma, Chronic Obstructive Pulmonary Disease (COPD), and other respiratory conditions characterized by bronchoconstriction and inflammation.

Pros and Cons

Pros

• Comprehensive Airway Management: Simultaneously targets muscle constriction and inflammatory responses for better symptom control.

• Convenient Dosing: The sustained-release (SR) technology helps maintain consistent drug levels in the body, often allowing for fewer daily doses.

• Prophylactic Use: Effective for preventing daytime and nighttime symptoms associated with chronic asthma or COPD.

Cons

• Not for Acute Rescue: This medication is designed for ongoing maintenance and will not relieve a sudden, acute breathing attack. An emergency rescue inhaler is required.

• Potential Side Effects: May cause common issues such as headache, dry mouth, gastrointestinal discomfort, or difficulty sleeping.

• Adherence is Crucial: For effectiveness, it must be taken regularly as prescribed, even if the patient feels well.

How to Use

• Administration: Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this will destroy the sustained-release mechanism of the Doxofylline layer.

• Consistency: Take the medication strictly as directed by the Physician. For best results, take it at the same time each day.

• Timing: Can typically be taken with or without food.

• Storage: Store in a dry place at a temperature not exceeding 25°C. Protect the medication from exposure to light.

Warning: This is a Schedule H Prescription Drug and should be used only under the guidance and prescription of a Registered Medical Practitioner.